Question: Why would an LP invest in a venture capital fund, but demand that the firm not publicly discuss the fund?
Answer: It wouldn’t.
Sounds obvious, but I had a moment of doubt while reading the lead story in this morning’s VentureWire (published by Dow Jones). It was about how Mohr Davidow Ventures has been ramping up its life sciences practice, and led with a news hook about how MDV had raised $600 million for its latest fund.
